Medical University Vienna, ENT - Univ. Clinic, Vienna, Austria.
Ther Clin Risk Manag. 2008 Oct;4(5):1009-22. doi: 10.2147/tcrm.s3229.
Azelastine nasal spray (Allergodil((R)), Lastin((R)), Afluon((R)); Meda AB, Stockholm, Sweden) is a fast-acting, efficacious and well-tolerated H1-receptor antagonist for the treatment of rhinitis. In addition it also has mast-cell stabilizing and anti-inflammatory properties, reducing the concentration of leukotrienes, kinins and platelet activating factor in vitro and in vivo, as well as inflammatory cell migration in rhinitis patients. Well-controlled studies in patients with seasonal allergic rhinitis (SAR), perennial rhinitis (PR) or vasomotor rhinitis (VMR) confirm that azelastine nasal spray has a rapid onset of action, and improves nasal symptoms associated with rhinitis such as nasal congestion and post-nasal drip. Azelastine nasal spray is effective at the lower dose of 1 spray as well at a dose of 2 sprays per nostril twice daily, but with an improved tolerability profile compared to the 2-spray per nostril twice daily regimen. Compared with intranasal corticosteroids, azelastine nasal spray has a faster onset of action and a better safety profile, showing at least comparable efficacy with fluticasone propionate (Flonase((R)); GSK, USA), and a superior efficacy to mometasone furoate (Nasonex((R)); Schering Plough, USA). In combination with fluticasone propionate, azelastine nasal spray exhibits greater efficacy than either agent used alone, and this combination may provide benefit for patients with difficult to treat seasonal allergic rhinitis. In addition, azelastine nasal spray can be used on an as-needed basis without compromising clinical efficacy. Compared with oral antihistamines, azelastine nasal spray also demonstrates superior efficacy and a more rapid onset of action, and is effective even in patients who did not respond to previous oral antihistamine therapy. Unlike most oral antihistamines, azelastine nasal spray is effective in alleviating nasal congestion, a particularly bothersome symptom for rhinitis sufferers. Azelastine nasal spray is well tolerated in both adults and children with allergic rhinitis. Bitter taste which seems to be associated with incorrect dosing technique is the most common side effect reported by patients, but this problem can be minimized by correct dosing technique.
盐酸氮卓斯汀鼻喷剂(Allergodil((R))、Lastin((R))、Afluon((R)))是一种快速起效、疗效确切且耐受性良好的 H1 受体拮抗剂,可用于治疗鼻炎。此外,它还具有稳定肥大细胞和抗炎作用,可降低体外和体内白细胞三烯、激肽和血小板激活因子的浓度,并减少鼻炎患者的炎症细胞迁移。在季节性过敏性鼻炎(SAR)、常年性鼻炎(PR)或血管舒缩性鼻炎(VMR)患者的对照研究中证实,盐酸氮卓斯汀鼻喷剂起效迅速,可改善鼻炎相关的鼻部症状,如鼻塞和后鼻滴注。盐酸氮卓斯汀鼻喷剂在较低剂量(1 喷)和较高剂量(每日 2 次,每侧鼻孔 2 喷)均有效,但与每日 2 次、每侧鼻孔 2 喷的方案相比,具有更好的耐受性。与鼻内皮质类固醇相比,盐酸氮卓斯汀鼻喷剂起效更快,安全性更好,与丙酸氟替卡松(Flonase((R));GSK,美国)疗效相当,与糠酸莫米松(Nasonex((R));先灵葆雅,美国)相比疗效更好。与丙酸氟替卡松联合使用时,盐酸氮卓斯汀鼻喷剂的疗效优于单独使用任何一种药物,对于治疗困难的季节性过敏性鼻炎患者,这种联合治疗可能会带来获益。此外,盐酸氮卓斯汀鼻喷剂按需使用不会影响临床疗效。与口服抗组胺药相比,盐酸氮卓斯汀鼻喷剂的疗效更好,起效更快,甚至对先前口服抗组胺治疗无效的患者也有效。与大多数口服抗组胺药不同,盐酸氮卓斯汀鼻喷剂可有效缓解鼻塞,这是鼻炎患者特别困扰的症状。盐酸氮卓斯汀鼻喷剂在成人和儿童过敏性鼻炎患者中均具有良好的耐受性。患者报告的最常见副作用是苦味,这似乎与不正确的给药技术有关,但通过正确的给药技术可以最大限度地减少这个问题。